Shimatsu, A. et al. 2022. OSILODROSTAT IS EFFECTIVE AND WELL- TOLERATED IN ASIAN AND NON-ASIAN PATIENTS WITH CUSHING’S DISEASE: RESULTS FROM LINC 3 (PHASE III STUDY). Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 75–76. DOI:https://doi.org/10.15605/jafes.037.AFES.118.